The Effect of Skin-to-skin Contact on Placental Separation Time, Type, Postpartum Hemorrhage and Comfort

NCT ID: NCT06011096

Last Updated: 2023-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

126 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-02

Study Completion Date

2023-08-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is aimed to determine the late cord clamping with early skin-to-skin contact in primiparous pregnant women who delivered vaginally, according to placental separation time, separation method, amount of postpartum bleeding and postpartum comfort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research is an experimental type randomized controlled trial. The data of the research gathered in the delivery room clinic of Erzurum City Hospital affiliated to the Ministry of Health in Erzurum city center between 02.11.2022 and 10.06.2023. The study was completed with 126 primiparous pregnants, 63 of whom were controls and 63 of whom were experimental, randomized in the clinic. "Personal Information Form" and "Postpartum Comfort Scale" prepared by the researcher were used to collect the data of the study.

control group

* Pregnant women who met the criteria for admission to the delivery room were selected, the institution's routine policies were implemented.
* The mother was informed about the study and written consent was obtained.
* Hospital routine practices continued until birth.
* The stopwatch is started the moment the baby is born.
* After birth, the umbilical cord was clamped immediately without skin-to-skin contact between the mother and the baby, and the baby was taken to routine care.
* Signs of placental separation were monitored with a stopwatch, and it was noted at what minute the symptoms were seen.
* Placental delivery time and separation type were noted in the relevant part of the form.
* According to the routines taken from each hospitalized patient in institutional policies, the volunteer's entry hemoglobin and hematocrit values were noted on the form.
* The Personal Information Form consisting of 22 questions and the Postpartum Comfort scale were administered to the mother at the end of the follow-up period in the delivery room (2 hours later).
* From the 6th hour blood values found in the hospital routine, the mother's hemoglobin and hematocrit values were noted on the form.

Experimental group

* Pregnant women who met the criteria for admission to the delivery room were selected, the institution's routine policies were implemented.
* The mother was informed about the study and written consent was obtained.
* Hospital routine practices continued until birth.
* The stopwatch is started the moment the baby is born.
* The baby was placed on the mother's chest, it was waited for 60-90 seconds in skin-to-skin contact, and breastfeeding was tried. At the end of the period, the umbilical cord was clamped and the baby was placed under a radiant heater and routine care was continued.
* Signs of placental separation were monitored with a stopwatch, and it was noted at what minute the symptoms were seen.
* Placental delivery time and separation type were noted in the relevant part of the form.
* According to the routines taken from each hospitalized patient in institutional policies, the volunteer's entry hemoglobin and hematocrit values were noted on the form.
* During the repair of episiotomy or desuria, if any, in the mother, skin-to-skin contact was made between the baby and the mother for 1 hour without disrupting the procedures.
* The Personal Information Form consisting of 22 questions and the Postpartum Comfort scale were administered to the mother at the end of the follow-up period in the delivery room (2 hours later).
* From the 6th hour blood values found in the hospital routine, the mother's hemoglobin and hematocrit values were noted on the form.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Comfort Postpartum Hemorrhage Midwifery Placenta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

the group with skin-to-skin contact and delayed cord clamping

In this arm, skin-to-skin contact and delayed cord clamping are performed between mother and baby.

Group Type EXPERIMENTAL

skin-to-skin contact and delayed cord clamping

Intervention Type OTHER

Placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated with skin-to-skin contact and late cord clamping after delivery.

The group without skin-to-skin contact and early cord clamping

In this arm, skin-to-skin contact and delayed cord clamping are not performed between mother and baby.

Group Type EXPERIMENTAL

avoiding skin-to-skin contact and early cord clamping

Intervention Type OTHER

After delivery, placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated without skin-to-skin contact and late cord clamping.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

skin-to-skin contact and delayed cord clamping

Placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated with skin-to-skin contact and late cord clamping after delivery.

Intervention Type OTHER

avoiding skin-to-skin contact and early cord clamping

After delivery, placental separation time, separation method, amount of postpartum bleeding and postpartum comfort were evaluated without skin-to-skin contact and late cord clamping.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* for pregnant women

1. Those who agreed to participate in the research
2. 18-49 years old
3. Firstborn (nulliparous)
4. Have 37-42 weeks of pregnancy
5. The baby in head presentation
6. No prenatal risk pregnancy
7. No risk during and after birth
* for newborns

1. Absence of any health problems or congenital diseases,
2. No need for resuscitation after birth.
3. APGAR score of 8 points or more

Exclusion Criteria

1. Births less than 37 weeks
2. Multiparity
3. Any complications in the mother or baby
4. Removal of the placenta by intervention rather than spontaneous separation
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bahar GÖBEL

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bahar GÖBEL

Midwife

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bahar Göbel

Role: PRINCIPAL_INVESTIGATOR

Midwife

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erzurum City Hospital

Erzurum, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Erzurum Atatürk Üniversitesi

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.